⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

January 1, 1989The Journal of Infectious Diseases

Spiramycin Is Not Effective in Treating Cryptosporidium Diarrhea in Infants: Results of A Double-Blind Randomized Trial

Dankwart Friedrich Wittenberg N. M. Miller J van den Ende

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

D. F. Wittenberg, N. M. Miller, J. Van Den Ende; Spiramycin Is Not Effective in Treating Cryptosporidium Diarrhea in Infants: Results of A Double-Blind Randomiz

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wittenberg et al. (1989) studied this question.

synapsesocial.com/papers/6a7e7aad9e800993579914f8 https://doi.org/10.1093/infdis/159.1.131

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Biological Sex as a Determinant of Neurological Outcomes During Zika Virus InfectionThe Journal of Infectious Diseases · 2026
2Immunity and vaccines for cryptosporidiosisThe Journal of Infectious Diseases · 2026
3Circulating Zika and dengue IgA-NS1 marks early postnatal exposure without significant association with congenital Zika syndrome-related microcephalyThe Journal of Infectious Diseases · 2026
4Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016–17 Through 2024–25The Journal of Infectious Diseases · 2026
5Predictors of Incident Hepatic Fibrosis and Steatotic Liver Disease–Associated Fibrosis Among Women with and without HIVThe Journal of Infectious Diseases · 2026
6Toward a Brighter Future in Vaccine Safety Science: A Call For Investments, Capitalizing on Scientific Opportunities and A National Vaccine Safety BoardThe Journal of Infectious Diseases · 2026
7IL-6 Blockade with Clazakizumab is Associated with Low Myeloid Cell Activation and Increased Type 2 Immune Responses in Non-survivors of COVID-19The Journal of Infectious Diseases · 2026
8EBV-infected cell lineage by EBER double-staining as a diagnostic and prognostic clue in pediatric EBV-related lymphoproliferative disorders: a Japanese central pathology cohort studyThe Journal of Infectious Diseases · 2026
9Impact of Dose on Norovirus Antibody Kinetics Following Infection or VaccinationThe Journal of Infectious Diseases · 2026
10Host Immune Biosignatures Predict Septic Shock and Mortality in Solid Organ Transplant Recipients With Gram-Negative BacteremiaThe Journal of Infectious Diseases · 2026

More from The Journal of Infectious Diseases

More from University of KwaZulu-Natal